Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients

Masatoshi Inagaki, Tatsuo Akechi, Toru Okuyama, Yuriko Sugawara, Hiroya Kinoshita, Yasuo Shima, Kimio Terao, Shuichi Mitsunaga, Atsushi Ochiai, Yosuke Uchitomi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: Previous studies have reported associations of depressive symptoms with pro-inflammatory cytokines, especially with interleukin-6 (IL-6) in noncancer subjects and cancer patients. Meanwhile, symptoms such as tiredness and appetite loss may be vegetative symptoms of depression when associated with other diagnostic criteria of depression. Such vegetative-type symptoms worsen during the last 6 months of life in cancer patients and may not be associated with affective depressive symptoms such as sadness and nervousness. This study explored associations between depressive symptoms and plasma IL-6 in terminally ill cancer patients whose survival period was confirmed to be less than 6 months by follow-up, with attention to differences in vegetative and affective depressive symptoms. Methods: Data from 112 consecutively recruited terminally ill cancer patients who registered at a palliative care unit without any active anticancer treatment were used. Plasma IL-6 levels were measured using an electrochemiluminescence assay. Depressive symptoms included in the DSM-IV and Cavanaugh criteria were assessed by structured interviews and were categorized into affective symptoms and vegetative symptoms. Affective symptoms were also measured with the depression subscale of the Hospital Anxiety and Depression Scale, which does not include vegetative symptoms. Results: Vegetative symptoms, such as appetite loss, insomnia, and fatigue, were significantly associated with IL-6 levels. However, neither of the affective symptoms nor their severity was associated with IL-6 levels. Conclusions: IL-6 was associated with vegetative depressive symptoms in terminally ill cancer patients but not with affective depressive symptoms, suggesting possible differences in the pathophysiological mechanisms between these sets of symptoms.

Original languageEnglish
Pages (from-to)2097-2106
Number of pages10
JournalSupportive Care in Cancer
Volume21
Issue number8
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Fingerprint

Terminally Ill
Affective Symptoms
Interleukin-6
Depression
Neoplasms
Appetite
Anxiety
Sleep Initiation and Maintenance Disorders
Palliative Care
Diagnostic and Statistical Manual of Mental Disorders
Fatigue
Interviews

Keywords

  • Cancer
  • Cytokine
  • Depression
  • Fatigue
  • Sickness behavior
  • Terminal illness

ASJC Scopus subject areas

  • Oncology

Cite this

Inagaki, M., Akechi, T., Okuyama, T., Sugawara, Y., Kinoshita, H., Shima, Y., ... Uchitomi, Y. (2013). Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. Supportive Care in Cancer, 21(8), 2097-2106. https://doi.org/10.1007/s00520-013-1767-x

Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. / Inagaki, Masatoshi; Akechi, Tatsuo; Okuyama, Toru; Sugawara, Yuriko; Kinoshita, Hiroya; Shima, Yasuo; Terao, Kimio; Mitsunaga, Shuichi; Ochiai, Atsushi; Uchitomi, Yosuke.

In: Supportive Care in Cancer, Vol. 21, No. 8, 08.2013, p. 2097-2106.

Research output: Contribution to journalArticle

Inagaki, M, Akechi, T, Okuyama, T, Sugawara, Y, Kinoshita, H, Shima, Y, Terao, K, Mitsunaga, S, Ochiai, A & Uchitomi, Y 2013, 'Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients', Supportive Care in Cancer, vol. 21, no. 8, pp. 2097-2106. https://doi.org/10.1007/s00520-013-1767-x
Inagaki, Masatoshi ; Akechi, Tatsuo ; Okuyama, Toru ; Sugawara, Yuriko ; Kinoshita, Hiroya ; Shima, Yasuo ; Terao, Kimio ; Mitsunaga, Shuichi ; Ochiai, Atsushi ; Uchitomi, Yosuke. / Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. In: Supportive Care in Cancer. 2013 ; Vol. 21, No. 8. pp. 2097-2106.
@article{2ec0dfe036474c2bbdf77db9cbb5ce2c,
title = "Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients",
abstract = "Purpose: Previous studies have reported associations of depressive symptoms with pro-inflammatory cytokines, especially with interleukin-6 (IL-6) in noncancer subjects and cancer patients. Meanwhile, symptoms such as tiredness and appetite loss may be vegetative symptoms of depression when associated with other diagnostic criteria of depression. Such vegetative-type symptoms worsen during the last 6 months of life in cancer patients and may not be associated with affective depressive symptoms such as sadness and nervousness. This study explored associations between depressive symptoms and plasma IL-6 in terminally ill cancer patients whose survival period was confirmed to be less than 6 months by follow-up, with attention to differences in vegetative and affective depressive symptoms. Methods: Data from 112 consecutively recruited terminally ill cancer patients who registered at a palliative care unit without any active anticancer treatment were used. Plasma IL-6 levels were measured using an electrochemiluminescence assay. Depressive symptoms included in the DSM-IV and Cavanaugh criteria were assessed by structured interviews and were categorized into affective symptoms and vegetative symptoms. Affective symptoms were also measured with the depression subscale of the Hospital Anxiety and Depression Scale, which does not include vegetative symptoms. Results: Vegetative symptoms, such as appetite loss, insomnia, and fatigue, were significantly associated with IL-6 levels. However, neither of the affective symptoms nor their severity was associated with IL-6 levels. Conclusions: IL-6 was associated with vegetative depressive symptoms in terminally ill cancer patients but not with affective depressive symptoms, suggesting possible differences in the pathophysiological mechanisms between these sets of symptoms.",
keywords = "Cancer, Cytokine, Depression, Fatigue, Sickness behavior, Terminal illness",
author = "Masatoshi Inagaki and Tatsuo Akechi and Toru Okuyama and Yuriko Sugawara and Hiroya Kinoshita and Yasuo Shima and Kimio Terao and Shuichi Mitsunaga and Atsushi Ochiai and Yosuke Uchitomi",
year = "2013",
month = "8",
doi = "10.1007/s00520-013-1767-x",
language = "English",
volume = "21",
pages = "2097--2106",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients

AU - Inagaki, Masatoshi

AU - Akechi, Tatsuo

AU - Okuyama, Toru

AU - Sugawara, Yuriko

AU - Kinoshita, Hiroya

AU - Shima, Yasuo

AU - Terao, Kimio

AU - Mitsunaga, Shuichi

AU - Ochiai, Atsushi

AU - Uchitomi, Yosuke

PY - 2013/8

Y1 - 2013/8

N2 - Purpose: Previous studies have reported associations of depressive symptoms with pro-inflammatory cytokines, especially with interleukin-6 (IL-6) in noncancer subjects and cancer patients. Meanwhile, symptoms such as tiredness and appetite loss may be vegetative symptoms of depression when associated with other diagnostic criteria of depression. Such vegetative-type symptoms worsen during the last 6 months of life in cancer patients and may not be associated with affective depressive symptoms such as sadness and nervousness. This study explored associations between depressive symptoms and plasma IL-6 in terminally ill cancer patients whose survival period was confirmed to be less than 6 months by follow-up, with attention to differences in vegetative and affective depressive symptoms. Methods: Data from 112 consecutively recruited terminally ill cancer patients who registered at a palliative care unit without any active anticancer treatment were used. Plasma IL-6 levels were measured using an electrochemiluminescence assay. Depressive symptoms included in the DSM-IV and Cavanaugh criteria were assessed by structured interviews and were categorized into affective symptoms and vegetative symptoms. Affective symptoms were also measured with the depression subscale of the Hospital Anxiety and Depression Scale, which does not include vegetative symptoms. Results: Vegetative symptoms, such as appetite loss, insomnia, and fatigue, were significantly associated with IL-6 levels. However, neither of the affective symptoms nor their severity was associated with IL-6 levels. Conclusions: IL-6 was associated with vegetative depressive symptoms in terminally ill cancer patients but not with affective depressive symptoms, suggesting possible differences in the pathophysiological mechanisms between these sets of symptoms.

AB - Purpose: Previous studies have reported associations of depressive symptoms with pro-inflammatory cytokines, especially with interleukin-6 (IL-6) in noncancer subjects and cancer patients. Meanwhile, symptoms such as tiredness and appetite loss may be vegetative symptoms of depression when associated with other diagnostic criteria of depression. Such vegetative-type symptoms worsen during the last 6 months of life in cancer patients and may not be associated with affective depressive symptoms such as sadness and nervousness. This study explored associations between depressive symptoms and plasma IL-6 in terminally ill cancer patients whose survival period was confirmed to be less than 6 months by follow-up, with attention to differences in vegetative and affective depressive symptoms. Methods: Data from 112 consecutively recruited terminally ill cancer patients who registered at a palliative care unit without any active anticancer treatment were used. Plasma IL-6 levels were measured using an electrochemiluminescence assay. Depressive symptoms included in the DSM-IV and Cavanaugh criteria were assessed by structured interviews and were categorized into affective symptoms and vegetative symptoms. Affective symptoms were also measured with the depression subscale of the Hospital Anxiety and Depression Scale, which does not include vegetative symptoms. Results: Vegetative symptoms, such as appetite loss, insomnia, and fatigue, were significantly associated with IL-6 levels. However, neither of the affective symptoms nor their severity was associated with IL-6 levels. Conclusions: IL-6 was associated with vegetative depressive symptoms in terminally ill cancer patients but not with affective depressive symptoms, suggesting possible differences in the pathophysiological mechanisms between these sets of symptoms.

KW - Cancer

KW - Cytokine

KW - Depression

KW - Fatigue

KW - Sickness behavior

KW - Terminal illness

UR - http://www.scopus.com/inward/record.url?scp=84879934016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879934016&partnerID=8YFLogxK

U2 - 10.1007/s00520-013-1767-x

DO - 10.1007/s00520-013-1767-x

M3 - Article

C2 - 23446881

AN - SCOPUS:84879934016

VL - 21

SP - 2097

EP - 2106

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 8

ER -